Introduction
Regulatory T cells (Tregs) play a principal role in immune reactions including autoimmunity, transplantation tolerance, anti-infectious immunity and cancer. These cells represent about <5% of the peripheral CD4+ T cell population and play a crucial role in the maintenance of immune homeostasis against self-antigens [1, 2] . Numerical or functional deficit of Treg cells is linked to many autoimmune diseases such as rheumatoid arthritis [3] , multiple sclerosis or type 1 diabetes. These Treg features result from their potent capacity to reduce the activation and expansion of conventional T cells [4] by suppressing their biological activities like proliferation and blocking the production of proinflammatory cytokines TNF alpha and IFNgamma, among others [5] .
The two main groups of Tregs represent natural Tregs (nTregs) and induced or adaptive Tregs (iTregs) [6] . nTregs originate in thymus and express high levels of the IL-2 receptor α-chain (CD25) [7] and the forkhead-winged helix transcription factor FoxP3, which is inevitable for their development and function [8, 9] . FoxP3 + iTregs arise in periphery from conventional naive CD4 + FoxP3 − T cells. Under the influence of suppressive cytokines and antigen-specific activation they develop into FoxP3 + Tregs. [6] . Today the most widely accepted phenotype for Tregs is the coexpression of CD4, CD25 (α-chain of the IL-2 receptor), and of FoxP3 [10] .
Mechanisms of Treg Function
Tregs can suppress a whole range of immune cells including B cells, NK cells, NKT cells, CD4 + or CD8 + T cells, and both monocytes and dendritic cells. The most important and extensively studied is the suppression of CD4 + CD25 -conventional T cells (TCONV). Main function of Tregs is to suppress the activation of naive TCONV, but they can also inhibit activated effector T cells and memory CD4 + [11] and CD8 + T cells [12] . Tregs can suppress their proliferation directly [13] without the presence of antigen presenting cells (APCs). There are evidences for either contact-dependent suppression or suppression via immunosuppressive cytokines or other factors. One efficient way to supppress immune responses is direct killing of CD4 + effector cells, which was described by Grossman et al., [14] . They have shown that upon CD3/CD46 activation human nTregs express the serine protease granzyme A and kill TCONV in a perforindependent manner without CD95-CD95L interaction.
Nevertheless, the main mechanism of suppression of Tregs consist in influencing the activation status of APCs. In this regard the key molecule is CTLA4, which competitively inhibits the binding of CD28 to its ligands CD80 and CD86 and thus inhibits co-stimulation of effector T cells. CTLA4 together with the adhesion molecule LFA-1 also downregulates the expression of CD80 and CD86 on APCs [15, 16] Treg cells express high levels of CD25 and consecutively deprive the environment of IL-2, which can also affect the survival of effector T cells.
Human and Mouse Differences
To describe all differences between human and mouse systems is not the topic of this rewiev. Shortly speaking, in mice most of 
Intracellular Markers

FoxP3
The transcription factor FoxP3 is regarded to be a lineage molecule for Tregs. It is neccessary for their thymic development, function and phenotype and is responsible for controlling the expression of a number of genes including suppresive cytokines and Treg surface molecules [8, 10, [77] . It became obvious, that the mere existence of an underlying disease (e.g., HIV infection) [76] or the in vitro activation [79] cause an intense CD127 down modulation on formerly CD127 + T effector cells.
FR4
The folate receptor (FR), is also known as the folic acid binding protein. There are four isoforms of the human FR: FR-α,-ß,-γ and-δ. They are expressed on epithelial cells, macrophages and malignant cells. Since FRs are overexpressed on approximately 40% of human cancers, folate conjugates have been used to deliver attached imaging and therapeutic agents sele ctively to malignant cells. Recently, FR-δ has been described also on human Tregs [80] . In mice has been described highly homologous molecule to human FR-δ, called FR4 [81] . Studies in mice determined that FR4 is expressed at particularly high amounts in nTregs and plays an important role in the maintenance of the Treg phenotype [82] . 
Other Surface Molecules
Conclusion
Finding a specific cell surface marker of Treg cells which would allow their identification and isolation was the topic of a past decade. Presumably no other Treg-specific positive surface marker shall be identified in the future, but revealing the molecule CD26 as another negative marker in combination with other listed molecules could slowly amend our possibilities in distinguishing this important population from effector T cells and improve our diagnostic possibilities. 
